These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 21449822

  • 1. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology.
    Li L, Zhao X, Yang C, Hu H, Qiao M, Chen D.
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1170-80. PubMed ID: 21449822
    [Abstract] [Full Text] [Related]

  • 2. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K, Praphairaksit N, Siraleartmukul K, Muangsin N.
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [Abstract] [Full Text] [Related]

  • 3. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY, Du YZ, Chen WW, Yuan H, Hu FQ.
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [Abstract] [Full Text] [Related]

  • 4. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
    Varshosaz J, Hassanzadeh F, Mardani A, Rostami M.
    Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
    [Abstract] [Full Text] [Related]

  • 5. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C, Zhao L, Dong Y, Zhang X, Lin J, Chen Z.
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [Abstract] [Full Text] [Related]

  • 6. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
    Munnier E, Cohen-Jonathan S, Linassier C, Douziech-Eyrolles L, Marchais H, Soucé M, Hervé K, Dubois P, Chourpa I.
    Int J Pharm; 2008 Nov 03; 363(1-2):170-6. PubMed ID: 18687392
    [Abstract] [Full Text] [Related]

  • 7. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
    Dreis S, Rothweiler F, Michaelis M, Cinatl J, Kreuter J, Langer K.
    Int J Pharm; 2007 Aug 16; 341(1-2):207-14. PubMed ID: 17478065
    [Abstract] [Full Text] [Related]

  • 8. [Optimization preparation of chansu-loaded solid lipid nanoparticles by central composite design and response surface method].
    Yang Y, Feng JF, Zhang H, Luo JY.
    Zhongguo Zhong Yao Za Zhi; 2006 Apr 16; 31(8):650-3. PubMed ID: 16830822
    [Abstract] [Full Text] [Related]

  • 9. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
    Mathew ST, Devi SG, KV S.
    AAPS PharmSciTech; 2007 Feb 23; 8(1):14. PubMed ID: 17408214
    [Abstract] [Full Text] [Related]

  • 10. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL, Zheng CL, Liu JP, Zhu JB.
    Yao Xue Xue Bao; 2013 May 23; 48(5):759-66. PubMed ID: 23888702
    [Abstract] [Full Text] [Related]

  • 11. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A, Chen J, Liu Y, Deng S, Wu Z, Huang Y, Ping Q.
    Drug Dev Ind Pharm; 2009 Nov 23; 35(11):1348-55. PubMed ID: 19832635
    [Abstract] [Full Text] [Related]

  • 12. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.
    Nanomedicine; 2007 Dec 23; 3(4):246-57. PubMed ID: 18068091
    [Abstract] [Full Text] [Related]

  • 13. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation.
    Wacker M, Zensi A, Kufleitner J, Ruff A, Schütz J, Stockburger T, Marstaller T, Vogel V.
    Int J Pharm; 2011 Jul 29; 414(1-2):225-32. PubMed ID: 21571055
    [Abstract] [Full Text] [Related]

  • 14. Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology.
    Li GY, Zhong M, Zhou ZD, Zhong YD, Ding P, Huang Y.
    Int J Biol Macromol; 2011 Dec 01; 49(5):970-8. PubMed ID: 21889529
    [Abstract] [Full Text] [Related]

  • 15. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J, Chen XG, Li YY, Liu CS.
    Nanomedicine; 2007 Dec 01; 3(4):258-65. PubMed ID: 17962086
    [Abstract] [Full Text] [Related]

  • 16. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S.
    Biomaterials; 2010 Jul 01; 31(21):5634-42. PubMed ID: 20430433
    [Abstract] [Full Text] [Related]

  • 17. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.
    Bansal A, Kapoor DN, Kapil R, Chhabra N, Dhawan S.
    Acta Pharm; 2011 Jun 01; 61(2):141-56. PubMed ID: 21684843
    [Abstract] [Full Text] [Related]

  • 18. [Preparation and in vitro characterization of apigemin-loaded nanostructured lipid carriers].
    Zhai YJ, Guo CY, Hou JN, Zhang WD, Zhai GX.
    Zhong Yao Cai; 2011 Jun 01; 34(6):962-5. PubMed ID: 22017012
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo.
    Miao FQ, An YL, Yang R, Tang QS, Zhang JQ.
    Biomed Mater Eng; 2014 Jun 01; 24(1):599-607. PubMed ID: 24211944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.